FIGURE 6:
Association of decreased SPRY4-IT1 with reduction in the levels of TJs in patients with gut barrier dysfunction. (A) Levels of SPRY4-IT1 in the intestinal mucosa in patients with increased gut permeability (IGP) or controls (Ctrl) as measured by Q-PCR analysis and normalized to Gapdh levels. Values are means ± SEM (n = 7). *p < 0.05 compared with controls. (B) In situ hybridization of SPRY4-IT1 with fluorescent LNA RNA detection probe in the intestinal mucosa described in A. (C) Immunohistochemical staining of TJ proteins in the intestinal mucosa described in A.